<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02388191</url>
  </required_header>
  <id_info>
    <org_study_id>2015P000436</org_study_id>
    <nct_id>NCT02388191</nct_id>
  </id_info>
  <brief_title>Naproxen for Pain Control With Intrauterine Device Insertion</brief_title>
  <official_title>Naproxen for Pain Control With Intrauterine Device Insertion: A Randomized Double-Blind Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Planned Parenthood League of Massachusetts</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Planned Parenthood League of Massachusetts</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is:

        1. To evaluate whether 550 mg of naproxen sodium reduces pain scores with IUD insertion on
           a 0-10cm visual analogue scale compared to placebo (primary outcome).

        2. To evaluate whether 550 mg of naproxen sodium reduces pain scores with tenaculum
           placement, uterine sounding and post-procedurally on a 0-10 cm visual analog scale
           compared to placebo (secondary outcomes).

        3. To establish if prophylactic naproxen sodium is acceptable for routine use prior to IUD
           insertion.

      Hypothesis: The administration of naproxen sodium, 550mg orally, 1 hour prior to IUD
      insertion will lead to a reduction in pain scores associated with IUD insertion compared to
      placebo.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain at Time of IUD Insertion Using a 10 cm (100 mm) Visual Analog Scale (VAS)</measure>
    <time_frame>Immediately after IUD insertion is complete</time_frame>
    <description>Pain at time of IUD insertion will be measured immediately upon completion of IUD insertion using a 100 mm visual analog scale (VAS). Patients are presented with a 100 mm line. On one end of the line, the anchor is &quot;0 = No pain&quot;. On the opposite end of the line, the anchor is &quot;10 = worst pain possible&quot;. Subjects are asked: &quot;Where 0 is no pain and 10 is the worst pain possible, please record your pain on the scale below.&quot; Research staff measure the distance between the &quot;0 = No pain&quot; anchor and the mark made by the patient (in mm) to score the measure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain With Tenaculum Placement Using a 10cm (100 mm) Visual Analog Scale (VAS)</measure>
    <time_frame>Immediately after tenaculum is placed on cervix</time_frame>
    <description>Pain with tenaculum placement will be measured immediately after tenaculum is placed on the cervix using a 10cm (100 mm) visual analog scale (VAS). Patients are presented with a 100 mm line. On one end of the line, the anchor is &quot;0 = No pain&quot;. On the opposite end of the line, the anchor is &quot;10 = worst pain possible&quot;. Subjects are asked: &quot;Where 0 is no pain and 10 is the worst pain possible, please record your pain on the scale below.&quot; Research staff measure the distance between the &quot;0 = No pain&quot; anchor and the mark made by the patient (in mm) to score the measure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain With Uterine Sounding Using a 10cm (100 mm) Visual Analog Scale (VAS)</measure>
    <time_frame>Immediately after uterine sounding</time_frame>
    <description>Pain with uterine sounding will be measured immediately after uterine sounding using a 10cm (100 mm) visual analog scale (VAS). Patients are presented with a 100 mm line. On one end of the line, the anchor is &quot;0 = No pain&quot;. On the opposite end of the line, the anchor is &quot;10 = worst pain possible&quot;. Subjects are asked: &quot;Where 0 is no pain and 10 is the worst pain possible, please record your pain on the scale below.&quot; Research staff measure the distance between the &quot;0 = No pain&quot; anchor and the mark made by the patient (in mm) to score the measure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain 5 Minutes After IUD Insertion Using a 10cm (100 mm) Visual Analog Scale (VAS)</measure>
    <time_frame>Five minutes after IUD insertion is complete</time_frame>
    <description>Pain 5 minutes after IUD insertion will occur five minutes after IUD insertion is complete using a 10cm (100 mm) visual analog scale (VAS). Patients are presented with a 100 mm line. On one end of the line, the anchor is &quot;0 = No pain&quot;. On the opposite end of the line, the anchor is &quot;10 = worst pain possible&quot;. Subjects are asked: &quot;Where 0 is no pain and 10 is the worst pain possible, please record your pain on the scale below.&quot; Research staff measure the distance between the &quot;0 = No pain&quot; anchor and the mark made by the patient (in mm) to score the measure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain 15 Minutes After IUD Insertion Using a 10cm (100 mm) Visual Analog Scale (VAS)</measure>
    <time_frame>Fifteen minutes after IUD insertion is complete</time_frame>
    <description>Pain 15 minutes after IUD insertion will occur 15 minutes after IUD insertion is complete using a 10cm (100 mm) visual analog scale (VAS). Patients are presented with a 100 mm line. On one end of the line, the anchor is &quot;0 = No pain&quot;. On the opposite end of the line, the anchor is &quot;10 = worst pain possible&quot;. Subjects are asked: &quot;Where 0 is no pain and 10 is the worst pain possible, please record your pain on the scale below.&quot; Research staff measure the distance between the &quot;0 = No pain&quot; anchor and the mark made by the patient (in mm) to score the measure.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">119</enrollment>
  <condition>Contraception</condition>
  <arm_group>
    <arm_group_label>Naproxen sodium</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>550 mg naproxen sodium</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Naproxen sodium</intervention_name>
    <description>550 mg, oral, on day 1. Number of Cycles: 1</description>
    <arm_group_label>Naproxen sodium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo tablet</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years or older

          -  Premenopausal

          -  Presenting for insertion of any IUD type (i.e. Mirena, Paragard, Skyla)

          -  English-speaking or non-English speaking with appropriate translator available

        Exclusion Criteria:

          -  Currently pregnant or pregnant within the last 4 weeks

          -  Not eligible for IUD insertion per PPLM's clinical protocols

          -  Presenting for IUD removal and reinsertion

          -  Any diagnosis of chronic pain (including fibromyalgia, endometriosis, dysmenorrhea,
             irritable bowel syndrome, interstitial cystitis)

          -  Pain medications taken within 12 hours of enrollment

          -  Misoprostol usage within 24 hours of enrollment

          -  Any known allergy or contraindication to non-steroidal anti-inflammatory drugs
             (including active renal disease, active hepatic disease, gastric ulcer disease or
             gastritis, and bleeding disorders)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Principal Investigator, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>PPLM</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Planned Parenthood League of Massachusetts</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2015</study_first_submitted>
  <study_first_submitted_qc>March 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2015</study_first_posted>
  <results_first_submitted>April 17, 2017</results_first_submitted>
  <results_first_submitted_qc>June 20, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">June 22, 2017</results_first_posted>
  <last_update_submitted>June 20, 2017</last_update_submitted>
  <last_update_submitted_qc>June 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Contraception</keyword>
  <keyword>Naproxen</keyword>
  <keyword>Intrauterine devices</keyword>
  <keyword>Pain Control</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Naproxen</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Naproxen Sodium</title>
          <description>550 mg naproxen sodium
Naproxen sodium: 550 mg, oral, on day 1. Number of Cycles: 1</description>
        </group>
        <group group_id="P2">
          <title>Placebo</title>
          <description>Placebo
Placebo tablet</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="59"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="58"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Patient did not receive IUD</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Naproxen Sodium</title>
          <description>550 mg naproxen sodium
Naproxen sodium: 550 mg, oral, on day 1. Number of Cycles: 1</description>
        </group>
        <group group_id="B2">
          <title>Placebo</title>
          <description>Placebo
Placebo tablet</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="58"/>
            <count group_id="B2" value="60"/>
            <count group_id="B3" value="118"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23.2" spread="3.9"/>
                    <measurement group_id="B2" value="24.3" spread="4.2"/>
                    <measurement group_id="B3" value="23.86" spread="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="58"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="118"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>African American or black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White or European American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Multiracial</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Marital status</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Married</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Single</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="54"/>
                    <measurement group_id="B3" value="105"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Highest level of education</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>High school or high school equivalency</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Some college or 2 year college</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 year college or Bachelor's degree</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Graduate or professional school</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diagnosed with chronic pain condition (yes)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diagnosed with depression (yes)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline stress, self-report</title>
          <description>This measure asked the following:
&quot;How stressed have you felt in the past week on a scale of 0-10, where 0 is not stressed at all and 10 is the most stressed ever&quot;.
Participants were then able to circle any whole number from 0-10 to indicate their answer.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4" lower_limit="3" upper_limit="6"/>
                    <measurement group_id="B2" value="4" lower_limit="3" upper_limit="6"/>
                    <measurement group_id="B3" value="4" lower_limit="3" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline sadness, self-report</title>
          <description>This measure asked the following:
&quot;How sad have you felt in the past week on a scale of 0-10, where 0 is not sad at all and 10 is the most sad ever&quot;.
Participants were then able to circle any whole number from 0-10 to indicate their answer.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2" lower_limit="1" upper_limit="3"/>
                    <measurement group_id="B2" value="3" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="B3" value="2" lower_limit="1" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline anxiety, self-report</title>
          <description>This measure asked the following:
&quot;On a scale of 0 to 10, where 0 is no anxiety and 10 is the most anxious you could be, how have you been feeling in the past week?&quot;.
Participants were then able to circle any whole number from 0-10 to indicate their answer.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3" lower_limit="2" upper_limit="5"/>
                    <measurement group_id="B2" value="4" lower_limit="2" upper_limit="5"/>
                    <measurement group_id="B3" value="3.5" lower_limit="2" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline pain tolerance, self report</title>
          <description>This measure asked the following:
&quot;How would you rate your pain tolerance (ability to handle pain) in general?&quot;. Response choices included: Very low (not much at all), Low, Moderate, High, or Very High (Can tolerate a lot of pain). Patients were asked to check the box of the choice that was correct for them.
Conversions to numerical values were as follows:
Very low = 1 Low = 2 Moderate = 3 High = 4 Very high = 5</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3" lower_limit="3" upper_limit="4"/>
                    <measurement group_id="B2" value="4" lower_limit="3" upper_limit="4"/>
                    <measurement group_id="B3" value="3" lower_limit="3" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Expected pain for IUD insertion</title>
          <description>This measure asked the following:
&quot;On a scale of 0 to 10, where 0 is no anxiety and 10 is the most anxious you could be, how anxious are you about the IUD placement?&quot;.
Participants were then able to circle any whole number from 0-10 to indicate their answer.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.5" lower_limit="32" upper_limit="60"/>
                    <measurement group_id="B2" value="50.3" lower_limit="28.8" upper_limit="62"/>
                    <measurement group_id="B3" value="49.3" lower_limit="29" upper_limit="61.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain at Time of IUD Insertion Using a 10 cm (100 mm) Visual Analog Scale (VAS)</title>
        <description>Pain at time of IUD insertion will be measured immediately upon completion of IUD insertion using a 100 mm visual analog scale (VAS). Patients are presented with a 100 mm line. On one end of the line, the anchor is &quot;0 = No pain&quot;. On the opposite end of the line, the anchor is &quot;10 = worst pain possible&quot;. Subjects are asked: &quot;Where 0 is no pain and 10 is the worst pain possible, please record your pain on the scale below.&quot; Research staff measure the distance between the &quot;0 = No pain&quot; anchor and the mark made by the patient (in mm) to score the measure.</description>
        <time_frame>Immediately after IUD insertion is complete</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Naproxen Sodium</title>
            <description>550 mg naproxen sodium
Naproxen sodium: 550 mg, oral, on day 1. Number of Cycles: 1</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo
Placebo tablet</description>
          </group>
        </group_list>
        <measure>
          <title>Pain at Time of IUD Insertion Using a 10 cm (100 mm) Visual Analog Scale (VAS)</title>
          <description>Pain at time of IUD insertion will be measured immediately upon completion of IUD insertion using a 100 mm visual analog scale (VAS). Patients are presented with a 100 mm line. On one end of the line, the anchor is &quot;0 = No pain&quot;. On the opposite end of the line, the anchor is &quot;10 = worst pain possible&quot;. Subjects are asked: &quot;Where 0 is no pain and 10 is the worst pain possible, please record your pain on the scale below.&quot; Research staff measure the distance between the &quot;0 = No pain&quot; anchor and the mark made by the patient (in mm) to score the measure.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69" lower_limit="52.5" upper_limit="80.5"/>
                    <measurement group_id="O2" value="66" lower_limit="50" upper_limit="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain With Tenaculum Placement Using a 10cm (100 mm) Visual Analog Scale (VAS)</title>
        <description>Pain with tenaculum placement will be measured immediately after tenaculum is placed on the cervix using a 10cm (100 mm) visual analog scale (VAS). Patients are presented with a 100 mm line. On one end of the line, the anchor is &quot;0 = No pain&quot;. On the opposite end of the line, the anchor is &quot;10 = worst pain possible&quot;. Subjects are asked: &quot;Where 0 is no pain and 10 is the worst pain possible, please record your pain on the scale below.&quot; Research staff measure the distance between the &quot;0 = No pain&quot; anchor and the mark made by the patient (in mm) to score the measure.</description>
        <time_frame>Immediately after tenaculum is placed on cervix</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Naproxen Sodium</title>
            <description>550 mg naproxen sodium
Naproxen sodium: 550 mg, oral, on day 1. Number of Cycles: 1</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo
Placebo tablet</description>
          </group>
        </group_list>
        <measure>
          <title>Pain With Tenaculum Placement Using a 10cm (100 mm) Visual Analog Scale (VAS)</title>
          <description>Pain with tenaculum placement will be measured immediately after tenaculum is placed on the cervix using a 10cm (100 mm) visual analog scale (VAS). Patients are presented with a 100 mm line. On one end of the line, the anchor is &quot;0 = No pain&quot;. On the opposite end of the line, the anchor is &quot;10 = worst pain possible&quot;. Subjects are asked: &quot;Where 0 is no pain and 10 is the worst pain possible, please record your pain on the scale below.&quot; Research staff measure the distance between the &quot;0 = No pain&quot; anchor and the mark made by the patient (in mm) to score the measure.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.3" lower_limit="20" upper_limit="55"/>
                    <measurement group_id="O2" value="31.8" lower_limit="17" upper_limit="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain With Uterine Sounding Using a 10cm (100 mm) Visual Analog Scale (VAS)</title>
        <description>Pain with uterine sounding will be measured immediately after uterine sounding using a 10cm (100 mm) visual analog scale (VAS). Patients are presented with a 100 mm line. On one end of the line, the anchor is &quot;0 = No pain&quot;. On the opposite end of the line, the anchor is &quot;10 = worst pain possible&quot;. Subjects are asked: &quot;Where 0 is no pain and 10 is the worst pain possible, please record your pain on the scale below.&quot; Research staff measure the distance between the &quot;0 = No pain&quot; anchor and the mark made by the patient (in mm) to score the measure.</description>
        <time_frame>Immediately after uterine sounding</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Naproxen Sodium</title>
            <description>550 mg naproxen sodium
Naproxen sodium: 550 mg, oral, on day 1. Number of Cycles: 1</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo
Placebo tablet</description>
          </group>
        </group_list>
        <measure>
          <title>Pain With Uterine Sounding Using a 10cm (100 mm) Visual Analog Scale (VAS)</title>
          <description>Pain with uterine sounding will be measured immediately after uterine sounding using a 10cm (100 mm) visual analog scale (VAS). Patients are presented with a 100 mm line. On one end of the line, the anchor is &quot;0 = No pain&quot;. On the opposite end of the line, the anchor is &quot;10 = worst pain possible&quot;. Subjects are asked: &quot;Where 0 is no pain and 10 is the worst pain possible, please record your pain on the scale below.&quot; Research staff measure the distance between the &quot;0 = No pain&quot; anchor and the mark made by the patient (in mm) to score the measure.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.8" lower_limit="45" upper_limit="75"/>
                    <measurement group_id="O2" value="58" lower_limit="39" upper_limit="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain 5 Minutes After IUD Insertion Using a 10cm (100 mm) Visual Analog Scale (VAS)</title>
        <description>Pain 5 minutes after IUD insertion will occur five minutes after IUD insertion is complete using a 10cm (100 mm) visual analog scale (VAS). Patients are presented with a 100 mm line. On one end of the line, the anchor is &quot;0 = No pain&quot;. On the opposite end of the line, the anchor is &quot;10 = worst pain possible&quot;. Subjects are asked: &quot;Where 0 is no pain and 10 is the worst pain possible, please record your pain on the scale below.&quot; Research staff measure the distance between the &quot;0 = No pain&quot; anchor and the mark made by the patient (in mm) to score the measure.</description>
        <time_frame>Five minutes after IUD insertion is complete</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Naproxen Sodium</title>
            <description>550 mg naproxen sodium
Naproxen sodium: 550 mg, oral, on day 1. Number of Cycles: 1</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo
Placebo tablet</description>
          </group>
        </group_list>
        <measure>
          <title>Pain 5 Minutes After IUD Insertion Using a 10cm (100 mm) Visual Analog Scale (VAS)</title>
          <description>Pain 5 minutes after IUD insertion will occur five minutes after IUD insertion is complete using a 10cm (100 mm) visual analog scale (VAS). Patients are presented with a 100 mm line. On one end of the line, the anchor is &quot;0 = No pain&quot;. On the opposite end of the line, the anchor is &quot;10 = worst pain possible&quot;. Subjects are asked: &quot;Where 0 is no pain and 10 is the worst pain possible, please record your pain on the scale below.&quot; Research staff measure the distance between the &quot;0 = No pain&quot; anchor and the mark made by the patient (in mm) to score the measure.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.5" lower_limit="4.5" upper_limit="29"/>
                    <measurement group_id="O2" value="26" lower_limit="14" upper_limit="39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pain 15 Minutes After IUD Insertion Using a 10cm (100 mm) Visual Analog Scale (VAS)</title>
        <description>Pain 15 minutes after IUD insertion will occur 15 minutes after IUD insertion is complete using a 10cm (100 mm) visual analog scale (VAS). Patients are presented with a 100 mm line. On one end of the line, the anchor is &quot;0 = No pain&quot;. On the opposite end of the line, the anchor is &quot;10 = worst pain possible&quot;. Subjects are asked: &quot;Where 0 is no pain and 10 is the worst pain possible, please record your pain on the scale below.&quot; Research staff measure the distance between the &quot;0 = No pain&quot; anchor and the mark made by the patient (in mm) to score the measure.</description>
        <time_frame>Fifteen minutes after IUD insertion is complete</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Naproxen Sodium</title>
            <description>550 mg naproxen sodium
Naproxen sodium: 550 mg, oral, on day 1. Number of Cycles: 1</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo
Placebo tablet</description>
          </group>
        </group_list>
        <measure>
          <title>Pain 15 Minutes After IUD Insertion Using a 10cm (100 mm) Visual Analog Scale (VAS)</title>
          <description>Pain 15 minutes after IUD insertion will occur 15 minutes after IUD insertion is complete using a 10cm (100 mm) visual analog scale (VAS). Patients are presented with a 100 mm line. On one end of the line, the anchor is &quot;0 = No pain&quot;. On the opposite end of the line, the anchor is &quot;10 = worst pain possible&quot;. Subjects are asked: &quot;Where 0 is no pain and 10 is the worst pain possible, please record your pain on the scale below.&quot; Research staff measure the distance between the &quot;0 = No pain&quot; anchor and the mark made by the patient (in mm) to score the measure.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="58"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.8" lower_limit="5" upper_limit="31"/>
                    <measurement group_id="O2" value="24" lower_limit="11" upper_limit="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Naproxen Sodium</title>
          <description>550 mg naproxen sodium
Naproxen sodium: 550 mg, oral, on day 1. Number of Cycles: 1</description>
        </group>
        <group group_id="E2">
          <title>Placebo</title>
          <description>Placebo
Placebo tablet</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="58"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Vasovagal episode</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="58"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Principal Investigator</name_or_title>
      <organization>Planned Parenthood League of Massachusetts</organization>
      <phone>6176298603</phone>
      <email>jfortin@pplm.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

